Cargando…
Downregulation of NMI promotes tumor growth and predicts poor prognosis in human lung adenocarcinomas
BACKGROUND: N-myc (and STAT) interactor (NMI) plays vital roles in tumor growth, progression, and metastasis. In this study, we identified NMI as a potential tumor suppressor in lung cancer and explored its molecular mechanism involved in lung cancer progression. METHODS: Human lung cancer cell line...
Autores principales: | Wang, Jingshu, Zou, Kun, Feng, Xu, Chen, Miao, Li, Cong, Tang, Ranran, Xuan, Yang, Luo, Meihua, Chen, Wangbing, Qiu, Huijuan, Qin, Ge, Li, Yixin, Zhang, Changlin, Xiao, Binyi, Kang, Lan, Kang, Tiebang, Huang, Wenlin, Yu, Xinfa, Wu, Xiaojun, Deng, Wuguo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5639741/ https://www.ncbi.nlm.nih.gov/pubmed/29025423 http://dx.doi.org/10.1186/s12943-017-0705-9 |
Ejemplares similares
-
RBFOX3 Promotes Tumor Growth and Progression via hTERT Signaling and Predicts a Poor Prognosis in Hepatocellular Carcinoma
por: Liu, Tianze, et al.
Publicado: (2017) -
NMI inhibits cancer stem cell traits by downregulating hTERT in breast cancer
por: Feng, Xu, et al.
Publicado: (2017) -
TFAP2B overexpression contributes to tumor growth and a poor prognosis of human lung adenocarcinoma through modulation of ERK and VEGF/PEDF signaling
por: Fu, Lingyi, et al.
Publicado: (2014) -
NMI and EMT
por: Samant, Rajeev S., et al.
Publicado: (2014) -
Berberine Targets AP-2/hTERT, NF-κB/COX-2, HIF-1α/VEGF and Cytochrome-c/Caspase Signaling to Suppress Human Cancer Cell Growth
por: Fu, Lingyi, et al.
Publicado: (2013)